Transcriptional expression of survivin and its splice variants in brain tumors in humans

Journal of Neurosurgery

Volumn 99, Issue 4, 2003, Pages 738-745

  Yamada, Yoshitaka ^b   Kuroiwa, Toshihiko ^b   Nakagawa, Toshimasa ^b   Kajimoto, Yoshinaga ^b   Dohi, Takehiko ^b   Azuma, Haruhito ^b   Tsuji, Motomu ^b   Kami, Kazuhiro ^b   Miyatake, Shin Ichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

Brain tumor; Glioma; Quantitative reverse transcription polymerase chain reaction; Splice variant; Survivin

Indexed keywords

GLYCERALDEHYDE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OXIDOREDUCTASE; PROTEIN; SURVIVIN; SURVIVIN 2B; SURVIVIN DELTAEX3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BENIGN TUMOR; BRAIN TUMOR; CLINICAL ARTICLE; GENETIC TRANSCRIPTION; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOPHYSIS ADENOMA; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; MENINGIOMA; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TISSUE DISTRIBUTION;

EID: 0141608911     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.99.4.0738     Document Type: Article

References (29)

1. Adida C, Crotty PL, McGrath J, et al: Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43-49, 1998
2. Altieri DC, Marchisio PC, Marchisio C: Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327-1333, 1999
3. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921, 1997
4. Asanuma K, Moriai R, Yajima T, et al: Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91:1204-1209, 2000
5. Ashhab Y, Alian A, Polliack A, et al: Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 495:56-60, 2001
6. Burger PC, Scheithauer BW, Paulus W: Pilocytic astrocytoma, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press, 2000, pp 45-51
7. Chakravarti A, Noll E, Black PM, et al: Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20:1063-1068, 2002
8. Chiodino C, Cesinaro AM, Ottani D, et al: Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 113:415-418, 1999
9. Grossman D, Kim PJ, Schechner JS, et al: Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 98:635-640, 2001
10. Hirohashi Y, Torigoe T, Maeda A, et al: An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res 8:1731-1739, 2002
11. Islam A, Kageyama H, Hashizume K, et al: Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, Survivin-β/2B. Med Pediatr Oncol 35:550-553, 2000
12. Islam A, Kageyama H, Takada N, et al: High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617-623, 2000
13. Ito T, Shiraki K, Sugimoto K, et al: Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31:1080-1085, 2000
14. Kappler M, Köhler T, Kampf C, et al: Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer (Pred Oncol) 95:360-363, 2001
15. Kawasaki H, Altieri DC, Lu CD, et al: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074, 1998
16. Konno R, Yamakawa H, Utsunomiya H, et al: Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 6:529-534, 2000
17. LaCasse EC, Baird S, Korneluk RG, et al: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247-3259, 1998
18. Li F, Ambrosini G, Chu EY, et al: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584, 1998
19. Lu CD, Altieri DC, Tanigawa N: Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812, 1998
20. Mahotka C, Krieg T, Krieg A, et al: Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer 100:30-36, 2002
21. Mahotka C, Wenzel M, Springer E, et al: Survivin-ΔEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59:6097-6102, 1999
22. Monzo M, Rosell R, Felip E, et al: A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17:2100-2104, 1999
23. Moriai R, Asanuma K, Kobayashi D, et al: Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res 21:595-600, 2001
24. O'Connor DS, Schechner JS, Adida C, et al: Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156:393-398, 2000
25. Rudin CM, Thompson CB: Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 48:267-281, 1997
26. Sarela AI, Macadam RC, Farmery SM, et al: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46:645-650, 2000
27. Shinozawa I, Inokuchi K, Wakabayashi I, et al: Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies. Leuk Res 24:965-970, 2000
28. Tamm I, Wang Y, Sausville E, et al: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas(CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320, 1998
29. Tanaka K, Iwamoto S, Gon G, et al: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127-134, 2000